Please login to the form below

genomes

This page shows the latest genomes news and features for those working in and with pharma, biotech and healthcare.

Covidian selection

Sometimes selection pressures work slowly, sometimes they work quickly. Daniel Lieberman’s excellent book, ‘The Story of the Human Body’ gives, for example, a fascinating description of how the human genome

Latest news

Merck gets first approval for MET inhibitor tepotinib in Japan

The approval comes on the back of a phase 2 study – called VISION – which enrolled patients with METex14-positive NSCLC based on a just-approved companion diagnostic developed by genome analysis
AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance

cases. It is also designed to protect against future variations of the virus, by targeting conserved epitopes from the whole virus genome. ... A vaccine to defend against current and future outbreaks of coronavirus and other respiratory viral pathogens
Allergan and Editas claim a CRISPR first in inherited blindness study

The historical CRISPR moment occurred in the phase 1/2 BRILLIANCE study, after the first LCA10 patient was dosed with the CRISPR genome editing medicine inside the body – or in vivo
Digital divergence

However, it’s the routineome, not the genome, we need to work on.
CRISPR gene-editing in cancer patients is safe, according to new study

The trial, which is the first sanctioned study to evaluate the clinical application of multiple CRISPR edits to the human genome, was undertaken by investigators at the Abramson Cancer Center of

More from news
Approximately 9 fully matching, plus 162 partially matching documents found.

Latest Intelligence

A snapshot of Congenica

Our genome interpretation alone represents a c.95% reduction in staff time and cost. ... Scalability is another key factor. A single human genome consists of over 100GB of data. The Congenica platform processes, analyses and interprets thousands of
A snapshot of Microbiotica

create a database of reference genomes. ... In two-and-a-half years we have built an organisation of over 35 people with all the key disciplines and have outgrown our space at the Wellcome Genome Campus.
25 Women Leaders in UK Healthcare

She is also senior responsible officer (SRO) for the NHS Genomics Programme and has played a crucial role in enabling the groundbreaking 100, 000 Genomes Project by ensuring these healthcare scientists ... centre run by Illumina, and an automated
25 Women Leaders in UK Healthcare (part 2)

23. DR LARISSA KERECUK. Rare disease leader. England’s groundbreaking 100, 000 Genomes Project hasn’t been a scientific endeavour achieved exclusively through lab technology – it has required thousands of rare ... Dr Kerecuk is the lead for the
Genomics integration: can the NHS rise to the challenge?

This time, it hopes to sequence five million genomes within the next five years. ... When the first human genome was sequenced it took 13 years and £2bn to come to completion.

More from intelligence
Approximately 1 fully matching, plus 34 partially matching documents found.

Latest appointments

Editas Medicine names James Mullen as chairman

He has previously served as CEO of Patheon. Genome editing company Editas Medicine has appointed James Mullen as chairman of the board of directors.
Editas Medicine adds to its board of directors

Jessica Hopfield will also serve on the genome editing firm's audit committee. ... Genome editing company Editas Medicine has strengthened its board of directors with the addition of Jessica Hopfield, who will also serve on the board's audit committee.
Former GSK CEO joins Synthego’s advisory board

I look forward to contributing to the company’s success as the business extends further into the genome engineering market.”. ... Andrew’s appointment strengthens the company’s position as a leader in genome engineering solutions.”.
Paul Stockdale joins Oxford BioDynamics as CFO

A spin-out from Oxford University, Oxford BioDynamics focuses on the discovery and development of epigenetic biomarkers based on regulatory genome architecture.
Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

They will join the board of directors. Genome editing group Intellia Therapeutics has appointed Moncef Slaoui and Frank Verwiel to join its board of directors at a time when the board ... We look forward to their guidance as we continue to advance our

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

Learning about Rare Genetic Disorders on Undiagnosed Children’s Day

The UK has become the first country to take Whole Genome Sequencing, a cutting-edge biotechnology, into mainstream healthcare. ... Rather than looking at the genetic makeup of just the 20, 000 genes known to cause disorders, the whole genome is analysed.
What is changing in cardiovascular disease care?

Another area of focus in identifying people at risk is genome mapping, particularly around rarer conditions.
A uniquely English genomic medicine service

This process can take years, but Genomics England believes whole genome sequencing could provide much faster results. ... Helping these patients will mean carrying out whole genome sequencing upfront, before other genetic tests are conducted.
Secrets of Pharma Advertising

Programmatic advertising that bombards you with ads for garden gnomes because you did a search on the human genome.
World AIDS Day 2018: Fighting the stigma surrounding HIV

10. Tenofovir – a nucleotide reverse transcriptase inhibitor (NtRTI). 11. Acts as a nucleotide analogue that competitively inhibits reverse transcriptase, the enzyme required for replication of the viral genome.